La EMA ha recomendado autorizar Frehemgo (denecimig) para la profilaxis de hemorragias en pacientes con hemofilia A.

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 September 2026 18 September 2026 https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-14-17-september-2026?&utm_medium=email&_hsenc=p2ANqtz-81_Flxp4-xGI-0WIDIKSeGuPHEA-a7JFnCoKXOZn9Sqs0q0KQE05Cg1T1vy-61b_gyvq1P966xCFEbjWH1EMWOxCMGSA&_hsmi=146512528&utm_content=146523058&utm_source=hs_email